Innovative semaglutide hydrogel may revolutionize diabetes treatment by reducing the need for injections to just once a month ...

GLP-1 drugs such as Ozempic and Wegovy are booming among consumers. That means Americans are downsizing in fitting rooms and ...

Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and ...

A study has identified the key role of lateral septum neurons in the effects of the anti-obesity drug liraglutide, offering ...

GLP-1 agonists may improve the disease course for a host of neurological and psychiatric disorders tied to inflammation, ...

Kerri Tanner, Pharm.D., the chief pharmacy officer of PayerAlly, says payers are looking for ways to rein in the escalating costs of specialty pharmacy drugs beyond the traditional techniques used by ...

Tirzepatide for diabetes was associated with superior cardiorenal benefits to GLP-1 agonists among patients with type 2 diabetes.

In people with diabetes, the "oatzempic" online diet fad may lead to increased glucose, decreased muscle mass, and ...

Gasherbrum Bio Inc. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes.

Chengdu Kanghong Pharmaceutical Co. Ltd. has synthesized indazolinone compounds acting as glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of cardiovascular ...

With the rising prescribing rates for glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter 2 (SGLT-2) inhibitors, 1 thorough patient medication reviews are crucial. A ...